Found: 9
Select item for more details and to access through your institution.
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
- Published in:
- BMC Cancer, 2010, v. 10, p. 646, doi. 10.1186/1471-2407-10-646
- By:
- Publication type:
- Article
Potent Influence of Bovine Serum Proteins in Experimental Dendritic Cell-Based Vaccination Protocols.
- Published in:
- Scandinavian Journal of Immunology, 2003, v. 58, n. 1, p. 43, doi. 10.1046/j.1365-3083.2003.01267.x
- By:
- Publication type:
- Article
The Hidden Mathematics of the Mars Exploration Rover Mission.
- Published in:
- Mathematical Intelligencer, 2007, v. 29, n. 1, p. 8, doi. 10.1007/BF02984753
- By:
- Publication type:
- Article
Characterization of Murine Dendritic Cells Derived from Adherent Blood Mononuclear Cells In Vitro.
- Published in:
- Scandinavian Journal of Immunology, 2000, v. 52, n. 2, doi. 10.1046/j.1365-3083.2000.00760.x
- By:
- Publication type:
- Article
Strain-Specific Variations in the Development of Dendritic Cells in Murine Bone-Marrow Cultures.
- Published in:
- Scandinavian Journal of Immunology, 2000, v. 51, n. 6, doi. 10.1046/j.1365-3083.2000.00732.x
- By:
- Publication type:
- Article
Pixantrone beyond monotherapy: a review.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
LONG‐TERM FOLLOW‐UP AND GENE EXPRESSION PROFILES ASSOCIATED WITH OUTCOME IN PATIENTS WITH RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS TREATED IN THE NORDIC P[R]EBEN TRIAL.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 309, doi. 10.1002/hon.3164_216
- By:
- Publication type:
- Article
FINAL ANALYSIS OF A NORDIC LYMPHOMA GROUP PHASE IB/IIA TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20‐POSITIVE TUMORS, RITUXIMAB IN RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.151_2880
- By:
- Publication type:
- Article
A PHASE 1/2 STUDY OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20+ TUMORS, RITUXIMAB IN PATIENTS WITH RELAPSED AGGRESSIVE B- OR T-CELL LYMPHOMAS-THE P[R]EBEN STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 423, doi. 10.1002/hon.2440_7
- By:
- Publication type:
- Article